SHERI HYATT: Open Payments
NPI 1770624462 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,987 in 113 payments from 26 companies in 2025. Trend: 2023 $1,709 · 2024 $1,457 · 2025 $2,987
Food & beverage: $2,987
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $447 |
| Lilly USA, LLC | 7 | $321 |
| Novo Nordisk Inc | 12 | $300 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $273 |
| Gilead Sciences, Inc. | 3 | $244 |
| Boston Scientific Corporation | 2 | $197 |
| AstraZeneca Pharmaceuticals LP | 4 | $180 |
| ABIOMED | 3 | $156 |
| GlaxoSmithKline, LLC. | 11 | $156 |
| Axsome Therapeutics, Inc. | 6 | $155 |
Products named: JARDIANCE, VRAYLAR, Ozempic, BREZTRI, General - Therapies, SHINGRIX, Livdelzi, Yeztugo.
Industry payments across CA — which companies pay providers there.
